Form 8-K - Current report:
SEC Accession No. 0001641172-25-012596
Filing Date
2025-05-28
Accepted
2025-05-28 07:00:25
Documents
15
Period of Report
2025-05-27
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 63298
2 EX-3.1 ex3-1.htm EX-3.1 13293
3 EX-99.1 ex99-1.htm EX-99.1 13631
4 GRAPHIC ex99-1_001.jpg GRAPHIC 3233
  Complete submission text file 0001641172-25-012596.txt   274705

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ogen-20250527.xsd EX-101.SCH 3018
6 XBRL LABEL FILE ogen-20250527_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE ogen-20250527_pre.xml EX-101.PRE 24167
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3772
Mailing Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236
Business Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32188 | Film No.: 25991122
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)